Your search for comorbidities returned 2916 results

Your search for comorbidities returned 2916 results

Sort Results:

Relevant Recent
Endocrinology Metabolism

Sellar Masses

Are You Sure the Patient Has a Sellar Mass? Sellar masses are common. Incidental sellar masses are present in about 10-15% of the adult population; however, the vast majority of incidentally found lesions are relatively small (less than 10 mm in greatest diameter). Approximately 90% of sellar masses are pituitary adenomas. However, there is a…
Obstetrics and Gynecology

Pelvic Organ Prolapse

Pelvic Organ Prolapse 1. What every clinician should know Definition and symptoms Pelvic organ prolapse is a quality of life condition characterized by the vaginal walls or uterine cervix protruding beyond or outside of the hymenal remnants. There are a myriad of symptoms that have been tied to pelvic organ prolapse but, in studies, the…
Endocrinology Metabolism

Short Stature: Endocrine Causes

Evaluation of the child with short stature Definition A child who is 2 standard deviations (SD) or more below the mean height for children of that sex and chronological age (and ideally of the same racial-ethnic group) is said to have short stature. A single measurement of height is much less reliable in assessing growth…

Atrial fibrillation: Rate Control: Options, Advantages, Disadvantages

I. Atrial Fibrillation: What every physician needs to know. There are three important reasons to control the ventricular rate in patients presenting with atrial fibrillation (AF). These are the patient’s symptomatic status, hemodynamic instability, and risk of developing tachycardia-medicated cardiomyopathy. Patients with untreated AF seek medical treatment for ventricular rates that may at times be…

Demyelinating Disease

OVERVIEW: What every practitioner needs to know Are you sure your patient has demyelinating disease? What are the typical findings for this disease? Demyelinating diseases are a class of related disorders in which the immune system, both B- and T-cells, inappropriately targets myelinated neurons and resulting in damage to the myelin sheath around neurons, injury…
Critical Care Medicine


Hemorrhage Related terms Continue Reading Bleeding disorders Hemostasis Coagulopathy Related conditions Thrombocytopenias: immune mediated thrombocytopenias, neonatal thrombocytopenias, inherited platelet function disorders. Immune mediated coagulopathies: hemolytic uremic syndrome, thrombotic thrombocytopenia purpura. Congenital bleeding disorders. Acquired bleeding disorders: bleeding in liver disease, bleeding in renal disease, disseminated intravascular coagulation. 1. Description of the problem What every clinician…
Obstetrics and Gynecology

Gestational Diabetes Mellitus

1. What every clinician should know Clinical features and incidence Gestational diabetes mellitus (GDM) is carbohydrate intolerance, less severe than overt diabetes, diagnosed during the second half of pregnancy. During pregnancy, all women develop relative insulin resistance. This is most likely related to placental hormones. Most pregnant women increase their insulin production and maintain euglycemia…
Infectious Diseases

Neurologic Disease in the HIV Patient

OVERVIEW: What every practitioner needs to know Are you sure your HIV patient has neurologic disease? What should you expect to find? Common presentations of neurologic disease in HIV patients Symptomatic presentations by anatomical location Clinical presentation of neurologic disease in HIV patients varies depending on the anatomical location of the problem. Brain (chronic) –…
Infectious Diseases

Rapidly Growing Nontuberculous Mycobacteria (NTM)

OVERVIEW: What every practitioner needs to know Are you sure your patient has disease due to rapidly growing nontuberculous mycobacteria? What should you expect to find? Nontuberculous mycobacteria (NTM) can infect almost any organ in the body, thus, signs and symptoms will vary depending on the site of infection. In general, NTM cause four different…
Hospital Medicine

Heparin-induced thrombocytopenia (HIT)

Heparin can lower the platelet count through two mechanisms: a direct effect on platelets that occurs within 2 days, usually resolves despite continued therapy, and is of no clinical consequence, or immune heparin-induced thrombocytopenia (HIT). The information below covers only (immune) HIT, a life-threatening condition with a high thrombosis risk caused by platelet-activating HIT antibodies.…
Next post in Hospital Medicine